Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy

被引：0
|
作者：
Moreno, S. Flores [1 ]
Paloma, J. Bautista [2 ]
机构：
[1] Andalusian Agcy Hlth Technol Assessment, Seville 41006, Spain
[2] Virgen Rocio Hosp, Seville, Spain
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 2008年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：866 / 867
页数：8
相关论文
共 50 条
  • [31] Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment
    Oca, Ana I.
    Perez-Sala, Alvaro
    Pariente, Ana
    Ochoa, Rodrigo
    Velilla, Sara
    Pelaez, Rafael
    Larrayoz, Ignacio M.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [32] Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration
    Modi, Yasha S.
    Tanchon, Carley
    Ehlers, Justis P.
    DRUG SAFETY, 2015, 38 (03) : 279 - 293
  • [33] Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration
    Jeganathan, V. Swetha E.
    Verma, Nitin
    CURRENT OPINION IN OPHTHALMOLOGY, 2009, 20 (03) : 223 - 225
  • [34] Adjuvant radiotherapy during anti-VEGF in neovascular age-related macular degeneration
    Rating, P.
    Freimuth, M. -A.
    Stuschke, M.
    Bornfeld, N.
    OPHTHALMOLOGE, 2017, 114 (04): : 370 - 374
  • [35] Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration
    Finger, Robert P.
    Wickremasinghe, Sanjeewa S.
    Baird, Paul N.
    Guymer, Robyn H.
    SURVEY OF OPHTHALMOLOGY, 2014, 59 (01) : 1 - 18
  • [36] Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration
    Luaces-Rodriguez, Andrea
    Mondelo-Garcia, Cristina
    Zarra-Ferro, Irene
    Gonzalez-Barcia, Miguel
    Aguiar, Pablo
    Fernandez-Ferreiro, Anxo
    Otero-Espinar, Francisco J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 573
  • [37] Choroidal Thickness Changes After Intravitreal Anti-VEGF Therapy for Age-Related Macular Degeneration: Ranibizumab Versus Aflibercept
    Gharbiya, Magda
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [38] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)
  • [39] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    International Ophthalmology, 2010, 30 (3) : 261 - 266
  • [40] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
12345